Search - tctmd.com

Displaying 1 - 20 of 66

Sort: Relevancy | Date

Presentation TCT 2025

Regulatory Approvals for Therapies for Patients with “Not Suitable for Conventional Therapy?"

Presenter: Jeffrey Popma

October 28, 2025

Presentation TCT 2025

TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis

Presenter: Thomas E. Waggoner

October 28, 2025

Presentation TCT 2025

Moving to Randomized SCAI A Shock CAD Phenotype Approval Studies: Barriers & Solutions

Presenter: Mitchell W. Krucoff

October 28, 2025

Presentation TCT 2025

Electrosurgical Tools in Structural Heart Interventions: How to Drive Best Practices, Device Development, and Regulatory Approval

Presenter: Adam B. Greenbaum

October 28, 2025

Presentation TCT 2025

Pragmatic, Adapted, and Augmented Trials: Ready for Regulatory Approval

Presenter: Sreekanth Vemulapalli

October 27, 2025

Presentation TCT 2025

TCT 704: Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients of Historically Underrepresented Racial and Ethnic Groups: A Sub-analysis of the HEAL-LAA Post Approval Study

Presenter: Seun Alli

October 27, 2025

Presentation TCT 2025

Comparative Outcomes of ICE vs. TEE Guided LACC with Amulet Device: Insights from EMERGE LAA Post-Approval Study

Presenter: Mohamad A. Alkhouli

October 26, 2025

Presentation TCT 2025

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

Presenter: Christina Lalani

October 26, 2025

News Daily News

SCAI/HRS Issue First Practice Guideline for LAAO

Yael L. Maxwell

August 06, 2025

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan

August 06, 2025

Podcast TCTMD Talking Points

Echocardiography and Quality Data

August 04, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Michael O'Riordan

July 14, 2025

News Daily News

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

Caitlin E. Cox

July 14, 2025

News Conference News NY Valves 2025

Promising Early Data With Navitor TAVI Valves

Yael L. Maxwell

July 02, 2025

Presentation NY Valves 2025

Outcomes of TEE vs. ICE-guided Left Atrial Appendage Closure Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Presenter: Seun Alli

June 26, 2025

Presentation NY Valves 2025

Outcomes in Patients Discharged on OAC vs. DAPT After Left Atrial Appendage Occlusion Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Presenter: Seun Alli

June 25, 2025

Presentation NY Valves 2025

Outcomes of Same-day vs. Delayed Discharge After LAAC Using a Fluoropolymer Coated Device: HEAL-LAA Post Approval Study Sub-analysis

Presenter: Jeremiah P. Depta

June 25, 2025

News Daily News

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Yael L. Maxwell

June 18, 2025

Advertisement

Regulatory Approvals for Therapies for Patients with “Not Suitable for Conventional Therapy?"

TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis

Moving to Randomized SCAI A Shock CAD Phenotype Approval Studies: Barriers & Solutions

Electrosurgical Tools in Structural Heart Interventions: How to Drive Best Practices, Device Development, and Regulatory Approval

Pragmatic, Adapted, and Augmented Trials: Ready for Regulatory Approval

TCT 704: Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients of Historically Underrepresented Racial and Ethnic Groups: A Sub-analysis of the HEAL-LAA Post Approval Study

Comparative Outcomes of ICE vs. TEE Guided LACC with Amulet Device: Insights from EMERGE LAA Post-Approval Study

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

SCAI/HRS Issue First Practice Guideline for LAAO

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Echocardiography and Quality Data

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

Promising Early Data With Navitor TAVI Valves

Outcomes of TEE vs. ICE-guided Left Atrial Appendage Closure Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Outcomes in Patients Discharged on OAC vs. DAPT After Left Atrial Appendage Occlusion Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Outcomes of Same-day vs. Delayed Discharge After LAAC Using a Fluoropolymer Coated Device: HEAL-LAA Post Approval Study Sub-analysis

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content